First COVID-19 vaccine approved for children aged 12 and above
The Hindu
Zydus Cadila's vaccine gets approval for emergency use: Govt
The Drug Controller General has granted emergency approval to the Zycov-D, a COVID-19 vaccine developed by the Ahmedabad based Zydus Cadilla group, on Friday, making it the first vaccine in India that can be administered to adults as well as those 12 and above. It's also the only DNA-based vaccine in the world and can be administered without a needle, purportedly minimising chances of reactions. Interim results from Phase-III Clinical Trials, in July, in over 28,000 volunteers, showed a primary efficacy of 66.6 % for symptomatic RT-PCR positive cases. "This has been the largest vaccine trial so far in India for COVID-19. This vaccine had already exhibited robust immunogenicity and tolerability and safety profile in the adaptive Phase I/II clinical trials carried out earlier. Both the Phase I/II and Phase III clinical trials have been monitored by an independent Data Safety Monitoring Board (DSMB)," the Department of Biotechnology said in a statement on Friday. The vaccine has been developed in partnership with the Department of Biotechnology under the ‘Mission COVID Suraksha', The three-dose vaccine once administered produces the spike protein of the SARS-CoV-2 virus and elicits an immune response. "The plug-and-play technology on which the plasmid DNA platform is based can be easily adapted to deal with mutations in the virus, such as those already occurring," the DBT noted. Renu Swarup, Secretary, DBT told The Hindu that with the approval, the vaccine would be available "very soon" and that stockpiling had already begun.More Related News
When Britain handed Hong Kong back to China in 1997, Beijing promised to retain the city’s Western-style civil liberties for 50 years. However, since the introduction of the 2020 law, Hong Kong authorities have severely limited free speech and assembly under the rubric of maintaining national security.